nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—Olopatadine—S100A1—ocular cancer	0.27	1	CrCbGaD
Doxepin—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000165	0.000226	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—HRAS—ocular cancer	0.000165	0.000226	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CDKN1A—ocular cancer	0.000164	0.000225	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—HRAS—ocular cancer	0.000163	0.000224	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	0.000162	0.000222	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000162	0.000222	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CDKN1B—ocular cancer	0.000161	0.00022	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	0.00016	0.00022	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCND1—ocular cancer	0.00016	0.000219	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—AKT1—ocular cancer	0.00016	0.000219	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—AKT1—ocular cancer	0.000159	0.000218	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—AKT1—ocular cancer	0.000159	0.000217	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000158	0.000216	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EP300—ocular cancer	0.000156	0.000214	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCND1—ocular cancer	0.000155	0.000212	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CDKN1A—ocular cancer	0.000155	0.000212	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000154	0.00021	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCND1—ocular cancer	0.000153	0.00021	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.000151	0.000207	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—AKT1—ocular cancer	0.000151	0.000206	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	0.00015	0.000205	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000149	0.000205	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000149	0.000204	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	0.000148	0.000203	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EP300—ocular cancer	0.000147	0.000202	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—AKT1—ocular cancer	0.000146	0.0002	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—ocular cancer	0.000146	0.000199	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—ocular cancer	0.000144	0.000198	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000144	0.000197	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000144	0.000197	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000143	0.000196	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EP300—ocular cancer	0.000142	0.000195	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EP300—ocular cancer	0.000141	0.000193	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000139	0.000191	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000139	0.000191	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—HRAS—ocular cancer	0.000139	0.000191	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000139	0.00019	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNA11—ocular cancer	0.000138	0.00019	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000188	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000136	0.000187	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—ocular cancer	0.000136	0.000186	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—ocular cancer	0.000136	0.000186	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000136	0.000186	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000135	0.000185	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000135	0.000184	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000134	0.000183	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—EP300—ocular cancer	0.000134	0.000183	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000133	0.000182	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.000133	0.000182	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.000132	0.00018	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000131	0.000179	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.00013	0.000178	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.00013	0.000178	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.00013	0.000177	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000129	0.000177	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000129	0.000176	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—ocular cancer	0.000128	0.000176	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—ocular cancer	0.000128	0.000175	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000127	0.000175	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000127	0.000174	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000127	0.000173	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000126	0.000173	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000126	0.000172	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000126	0.000172	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.000172	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000125	0.000171	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000124	0.000171	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MDM2—ocular cancer	0.000124	0.00017	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—ocular cancer	0.000124	0.00017	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000124	0.00017	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—ocular cancer	0.000124	0.00017	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MDM2—ocular cancer	0.000124	0.00017	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MDM2—ocular cancer	0.000123	0.000169	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—ocular cancer	0.000123	0.000168	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—ocular cancer	0.000123	0.000168	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—ocular cancer	0.000123	0.000168	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000122	0.000168	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MDM2—ocular cancer	0.000122	0.000167	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000122	0.000167	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.000121	0.000166	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.000121	0.000166	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000121	0.000165	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.00012	0.000164	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.00012	0.000164	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—EP300—ocular cancer	0.000118	0.000162	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000118	0.000162	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000118	0.000161	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000118	0.000161	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000117	0.000161	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000116	0.000158	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000116	0.000158	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000116	0.000158	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000116	0.000158	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000116	0.000158	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.000115	0.000158	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000115	0.000158	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—ocular cancer	0.000115	0.000158	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000115	0.000157	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—ocular cancer	0.000115	0.000157	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000114	0.000157	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000114	0.000157	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000114	0.000156	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—ocular cancer	0.000114	0.000156	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000113	0.000155	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.000113	0.000155	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000113	0.000155	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000113	0.000155	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	0.000113	0.000154	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000113	0.000154	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000112	0.000154	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000112	0.000154	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000112	0.000153	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000112	0.000153	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—ocular cancer	0.000112	0.000153	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	0.000112	0.000153	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	0.000111	0.000153	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000111	0.000152	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	0.00011	0.000151	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—ocular cancer	0.00011	0.000151	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.00011	0.000151	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.00011	0.000151	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—EP300—ocular cancer	0.000109	0.000149	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000108	0.000149	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—ocular cancer	0.000108	0.000148	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—ocular cancer	0.000108	0.000148	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—ocular cancer	0.000108	0.000147	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—ocular cancer	0.000107	0.000146	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000107	0.000146	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—ocular cancer	0.000106	0.000146	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000106	0.000145	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—ocular cancer	0.000105	0.000144	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000105	0.000144	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000105	0.000144	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1A—ocular cancer	0.000105	0.000143	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000104	0.000143	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000104	0.000143	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000104	0.000143	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	0.000104	0.000142	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000104	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.000103	0.000142	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	0.000103	0.000141	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000103	0.000141	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000102	0.00014	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000102	0.00014	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—ocular cancer	0.000102	0.00014	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—ocular cancer	0.000102	0.00014	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—ocular cancer	0.000102	0.000139	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—ocular cancer	0.000101	0.000139	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—ocular cancer	0.000101	0.000139	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—ocular cancer	0.000101	0.000138	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—ocular cancer	0.000101	0.000138	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—ocular cancer	0.000101	0.000138	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—ocular cancer	0.0001	0.000138	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—ocular cancer	0.0001	0.000137	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—ocular cancer	0.0001	0.000137	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.0001	0.000137	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—ocular cancer	9.99e-05	0.000137	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—ocular cancer	9.98e-05	0.000137	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—ocular cancer	9.96e-05	0.000136	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—ocular cancer	9.93e-05	0.000136	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—ocular cancer	9.9e-05	0.000136	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—ocular cancer	9.86e-05	0.000135	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—ocular cancer	9.8e-05	0.000134	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—ocular cancer	9.77e-05	0.000134	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—ocular cancer	9.75e-05	0.000134	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—ocular cancer	9.74e-05	0.000133	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	9.72e-05	0.000133	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—ocular cancer	9.65e-05	0.000132	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—ocular cancer	9.59e-05	0.000131	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	9.56e-05	0.000131	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	9.54e-05	0.000131	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—ocular cancer	9.49e-05	0.00013	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—ocular cancer	9.43e-05	0.000129	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	9.29e-05	0.000127	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—ocular cancer	9.08e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—ocular cancer	9.07e-05	0.000124	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—ocular cancer	8.9e-05	0.000122	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—ocular cancer	8.84e-05	0.000121	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—ocular cancer	8.82e-05	0.000121	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—ocular cancer	8.7e-05	0.000119	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—ocular cancer	8.68e-05	0.000119	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—ocular cancer	8.68e-05	0.000119	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—ocular cancer	8.66e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—ocular cancer	8.65e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—ocular cancer	8.63e-05	0.000118	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—ocular cancer	8.62e-05	0.000118	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—ocular cancer	8.61e-05	0.000118	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—ocular cancer	8.6e-05	0.000118	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—ocular cancer	8.56e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—ocular cancer	8.54e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—ocular cancer	8.52e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—ocular cancer	8.52e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—ocular cancer	8.52e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	8.5e-05	0.000116	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—ocular cancer	8.27e-05	0.000113	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—ocular cancer	8.22e-05	0.000113	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—ocular cancer	8.19e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—ocular cancer	8.08e-05	0.000111	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—ocular cancer	8.01e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—ocular cancer	8e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—ocular cancer	7.91e-05	0.000108	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—ocular cancer	7.91e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	7.89e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—ocular cancer	7.87e-05	0.000108	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—ocular cancer	7.87e-05	0.000108	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—ocular cancer	7.69e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—ocular cancer	7.65e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—ocular cancer	7.53e-05	0.000103	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—ocular cancer	7.51e-05	0.000103	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—ocular cancer	7.26e-05	9.94e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—ocular cancer	7.23e-05	9.91e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—ocular cancer	7.15e-05	9.8e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—ocular cancer	7.14e-05	9.78e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—ocular cancer	7.13e-05	9.76e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—ocular cancer	7.1e-05	9.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—ocular cancer	7.08e-05	9.7e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—ocular cancer	7.08e-05	9.69e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—ocular cancer	7.01e-05	9.61e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—ocular cancer	7.01e-05	9.61e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—ocular cancer	6.99e-05	9.58e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—ocular cancer	6.98e-05	9.56e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—ocular cancer	6.95e-05	9.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—ocular cancer	6.94e-05	9.51e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—ocular cancer	6.83e-05	9.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—ocular cancer	6.82e-05	9.34e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—ocular cancer	6.79e-05	9.31e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—ocular cancer	6.77e-05	9.28e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—ocular cancer	6.76e-05	9.25e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—ocular cancer	6.71e-05	9.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—ocular cancer	6.69e-05	9.16e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—ocular cancer	6.65e-05	9.11e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—ocular cancer	6.56e-05	8.99e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—ocular cancer	6.5e-05	8.9e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—ocular cancer	6.21e-05	8.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—ocular cancer	6.13e-05	8.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—ocular cancer	6.03e-05	8.26e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—ocular cancer	6.02e-05	8.24e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—ocular cancer	6e-05	8.22e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—ocular cancer	5.99e-05	8.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—ocular cancer	5.98e-05	8.19e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—ocular cancer	5.92e-05	8.11e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—ocular cancer	5.91e-05	8.09e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—ocular cancer	5.49e-05	7.52e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—ocular cancer	4.65e-05	6.37e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—ocular cancer	4.63e-05	6.34e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—ocular cancer	4.54e-05	6.22e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—ocular cancer	4.28e-05	5.86e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—ocular cancer	4.24e-05	5.81e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—ocular cancer	3.62e-05	4.96e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—ocular cancer	2.8e-05	3.83e-05	CbGpPWpGaD
